SFX by Ex Libris Inc.

Title:	Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms
Source:	Science [0036-8075] Bonni, A yr:1999

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Downward, J. "Targeting RAS signalling pathways in cancer therapy." Nature reviews. Cancer 3.1 (2003): 11-22.
description	2.	Gotoh, Y E. "Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery." Cell 91.2 (1997): 231-41.
description	3.	Yarden, Y. "The EGFR family and its ligands in human cancer: signalling mechanisms and therapeutic opportunities." European journal of cancer 37.4 (2001): 3-8.
description	4.	MOSMANN, T. "RAPID COLORIMETRIC ASSAY FOR CELLULAR GROWTH AND SURVIVAL - APPLICATION TO PROLIFERATION AND CYTO-TOXICITY ASSAYS." Journal of immunological methods 65.1-2 (1983): 55-63.
description	5.	Tan, Y. "p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway." The Journal of biological chemistry 274.49 (2000): 34859-67.
description	6.	Arden, A. "Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor." Cell 96.6 (1999): 857-68.
description	7.	Blum, R. "Tailoring Ras-pathway--inhibitor combinations for cancer therapy." Drug resistance updates 8.6 (2006): 369-80.
description	8.	del Peso, L. "Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt." Science 278.5338 (1997): 687-9.
description	9.	Nahta, R. "Herceptin: mechanisms of action and resistance." Cancer Letters 232.2 (2006): 123-38.
description	10.	Zhan, L. "Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in Carcinoma." Cell 135.5 (2008): 865-878.
description	11.	Lowy, D. "Function and regulation of RAS." Annual review of biochemistry 62.1 (1993): 851-891.
description	12.	Bos, J L L. "ras oncogenes in human cancer: a review." Cancer research 49.17 (1989): 4682-4689.
description	13.	Whitfield, J. "Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release." Neuron 29.3 (2001): 629-643.
description	14.	Normanno, N. "Epidermal growth factor receptor (EGFR) signaling in cancer." Gene 366.1 (2006): 2-16.
description	15.	Sebastian S, S. "The complexity of targeting EGFR signalling in cancer: From expression to turnover." Biochimica et biophysica acta. Reviews on cancer 1766.1 (2006): 120-139.
description	16.	DENIZOT, F. "RAPID COLORIMETRIC ASSAY FOR CELL-GROWTH AND SURVIVAL - MODIFICATIONS TO THE TETRAZOLIUM DYE PROCEDURE GIVING IMPROVED SENSITIVITY AND RELIABILITY." Journal of immunological methods 89.2 (1986): 271-277.
description	17.	Yarden, Y. "The EGFR family and its ligands in human cancer." European journal of cancer 37.supplement 4 (2001): 3-8.
description	18.	Vega Avila, E. "An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells." Proceedings of the Western Pharmacology Society 54 (2011): 10-4.
description	19.	Nebreda, A R R. "Perspectives: signal transduction. Cell survival demands some Rsk." Science 286.5443 (1999): 1309-10.
description	20.	Cardone, J C H. "Regulation of cell death protease caspase-9 by phosphorylation." Science 282.5392 (1998): 1318-21.